ÂÜÀòÂÒÂ×

Luke Hoyt is an experienced financial professional with a robust background in financial planning and analysis. Currently serving as the Financial Planning and Analysis Manager at Zentalis Pharmaceuticals since June 2022, Luke previously held similar roles at Sorrento Therapeutics, where responsibilities included providing financial updates and analysis for multiple departments, as well as corporate analysis for both Sorrento and Scilex. Prior experience includes tenure at Flexsteel Industries as a Senior Financial Analyst, where insights into financial performance were developed, and at Northrop Grumman as a Financial Analyst/Cost Account Manager overseeing significant operating budgets. Luke's career began in the United States Air Force, where responsibilities included oversight of cryptographic programs and network operations support.